Chemoprevention of human actinic keratoses by topical DL-α-tocopherol

Cancer Prevention Research

Volumn 2, Issue 4, 2009, Pages 394-400

  Foote, Janet A ^a,b   Ranger Moore, James R ^a,b   Einspahr, Janine G ^a   Saboda, Kathylynn ^a   Kenyon, Jaime ^c   Warneke, James ^a   Miller, Richard C ^a   Goldman, Rayna ^a   Xu, Min Jian ^a   Roe, Denise J ^a,b   Alberts, David S ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; CYCLINE; PLACEBO; POLYAMINE; PROTEIN P53; PUTRESCINE; RETINOL; SPERMIDINE; SPERMINE; UNCLASSIFIED DRUG; VANICREME; ANTIOXIDANT;

ACTINIC KERATOSIS; ADULT; AGED; ARTICLE; CANCER PREVENTION; CHEMOPROPHYLAXIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG WITHDRAWAL; DRY SKIN; FEMALE; FOREARM; HUMAN; HUMAN TISSUE; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PRURITUS; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS; SKIN ABSORPTION; SKIN BURNING SENSATION; SKIN CARCINOGENESIS; SKIN DEFECT; SKIN REDNESS; SQUAMOUS CELL CARCINOMA; SUN EXPOSURE; TREATMENT DURATION; TUMOR PROMOTION; DRUG EFFECT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOHISTOCHEMISTRY; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; AGED; ALPHA-TOCOPHEROL; ANTIOXIDANTS; BIOGENIC POLYAMINES; CHEMOPREVENTION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATOSIS, ACTINIC; MALE; PROLIFERATING CELL NUCLEAR ANTIGEN; TUMOR SUPPRESSOR PROTEIN P53;

EID: 67549133535     PISSN: 19406207     EISSN: None     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-08-0210     Document Type: Article

References (36)

1. Johnson TM, Dolan OM, Hamilton TA, Lu MC, Swanson NA, Lowe L. Clinical and histologic trends of melanoma. J Am Acad Dermatol 1998;38:681-686
2. Grossman D, Leffell DJ. The molecular basis of nonmelanoma skin cancer: new understanding. Arch Dermatol 1997;133:1263-1270 (Pubitemid 27443819)
3. Christenson LJ, Borrowman TA, Vachon CM, et al. Incidence of basal cell and squamous cell carcinomas in a population younger than 40 years. JAMA 2005;294:681-690
4. Purdue MP, Freeman LE, Anderson WF, Tucker MA. Recent trends in incidence of cutaneous melanoma among U.S. Caucasian young adults. J Invest Dermatol 2008;128:2905-2908
5. Rhie G, Shin MH, Seo JY, et al. Aging- and photoaging-dependent changes of enzymic and nonenzymic antioxidants in the epidermis and dermis of human skin in vivo. J Invest Dermatol 2001;117:1212-1217 (Pubitemid 34205920)
6. Thiele JJ. Oxidative targets in the stratum corneum. A new basis for antioxidative strategies. Skin Pharmacol Appl Skin Physiol 2001;14 Suppl 1:87-91.
7. Gensler HL, Magdaleno M. Topical vitamin E inhibition of immunosuppression and tumorigenesis induced by ultraviolet irradiation. Nutr Cancer 1991;15:97-106.
8. Gensler HL, Aickin M, Peng Y-M, Xu M. Importance of the form of topical vitamin E for prevention of photocarcinogenesis. Nutr Cancer 1996;26:183-191 (Pubitemid 26300197)
9. Marks R, Rennie G, Selwood TS. Malignant transformation of solar keratoses to squamous cell carcinoma. Lancet 1988;1:795-797 (Pubitemid 18094914)
10. Salasche SJ. Epidemiology of actinic keratoses and squamous cell carcinoma. J Am Acad Dermatol 2000;42:S4-7.
11. Nelson MA, Einspahr JG, Alberts DS, et al. Analysis of the p53 gene in human precancerous actinic keratosis lesions and squamous cell cancers. Cancer Lett 1994;85:23-29
12. Einspahr JG, Alberts DS, Warneke JA, et al. Relationship of p53 mutations to epidermal cell proliferation and apoptosis in human UV-induced skin carcinogenesis. Neoplasia 1999;1:468-475
13. Pennys NS, Bogaert M, Serfling U, Sisto M. PCNA expression in cutaneous keratinous neoplasms and verruca vulgaris. Am J Pathol 1992;141:139-142
14. Saida T, Dohi S, Sadaki M, Tokuda Y, Idegawa S, Takasaki Y. Distribution patterns and frequency of proliferating cells in cutaneous keratinocytic neoplasms. J Am Acad Dermatol 1992;26:744-748
15. Geary WA, Cooper PH. Proliferating cell nuclear antigen (PCNA) in common epidermal lesions. J Cutaneous Pathol 1992;19:458-468
16. Russell DH. The roles of the polyamines, putrescine, spermidine, and spermine in normal and malignant tissues. Life Sci 1973;13:1635-1647
17. Einspahr JG, Nelson MA, Saboda K, Warneke J, Bowden GT, Alberts DS. Modulation of biologic endpoints by topical difluoromethylornithine (DFMO), in subjects at high-risk for nonmelanoma skin cancer. Clin Cancer Res 2002;8:149-155 (Pubitemid 34101471)
18. Peng YM, Peng YS, Lin Y. A nonsaponification method for the determination of carotenoids, retinoids, and tocopherols in solid human tissues. Cancer Epidemiol Biomarkers Prev 1993;2:139-144
19. Alberts DS, Goldman R, Xu MJ, et al. Disposition and metabolism of topically administered α-tocopherol acetate: a common ingredient of commercially available sunscreens and cosmetics. Nutr Cancer 1996;26:193-201. (Pubitemid 26300198)
20. Minocha SC, Minocha R, Robie CA. High-performance liquid chromatographic method for the determination of dansyl-polyamines. J Chromatogr 1990;511:177-183 (Pubitemid 20197931)
21. Redman C, Xu MJ, Peng YM, et al. Involvement of polyamines in selenomethionine induced apoptosis and mitotic alterations in human tumor cells. Carcinogenesis 1997;18:1195-1202 (Pubitemid 28132511)
22. Einspahr J, Alberts DS, Aickin M, et al. Evaluation of proliferating cell nuclear antigen as a surrogate end point biomarker in actinic keratosis and adjacent, normal-appearing, and non-sun-exposed human skin samples. Cancer Epidemiol Biomarkers Prev 1996;5:343-348 (Pubitemid 26139116)
23. Einspahr J, Alberts DS, Aickin M, et al. Expression of p53 protein in actinic keratosis, adjacent, normal-appearing, and non-sun-exposed human skin. Cancer Epidemiol Biomarkers Prev 1997;6:583-587 (Pubitemid 27342680)
24. Stata Corporation. Stata statistical software: release 10.0. College Station (TX): Stata Corporation.
25. SAS Institute, Incorporated (1989-1996 Copyright). SAS Statistical Software System version 9.1. Cary (NC): SAS Institute, Incorporated.
26. SPSS for Windows, release 9.0. Chicago: SPSS, Inc.; 1999.
27. Moon TE, Levine N, Cartmel B, et al, Southwest Skin Cancer Prevention Study Group. Effect of retinol in preventing squamous cell skin cancer in moderate-risk subjects: a randomized, double-blind, controlled trial. Cancer Epidemiol Biomarkers Prev 1997;6:949-956 (Pubitemid 27481644)
28. Moon TE, Levine N, Cartmel B, Bangert JL. Retinoids in the prevention of skin cancer. Cancer Lett 1997;114:203-205
29. O'Brien TG, Megosh LC, Gilliard G, Peralta Soler A. Ornithine decarboxylase overexpression is a sufficient condition for tumor promotion in mouse skin. Cancer Res 1997;57:2630-2637 (Pubitemid 27283772)
30. Peralta Soler A, Gilliard G, Megosh L, George K, O'Brien TG. Polyamines regulate expression of the neoplastic phenotype in mouse skin. Cancer Res 1998;58:1654-1659 (Pubitemid 28215088)
31. Joshi M. The importance of L-arginine metabolism in melanoma: an hypothesis for the role of nitric oxide and polyamines in tumor angiogenesis. Free Radi Biol Med 1997;22:573-578 (Pubitemid 27020133)
32. Seiler N, Knödgen B. Effects of ultraviolet light on epidermal polyamine metabolism. Biochem Med 1979;21:168-181 (Pubitemid 9213944)
33. In: Cohen SS, editor. A guide to the polyamines. New York: Oxford University Press; 1998.
34. Khettab N, Amory M-C, Briand G, et al. Photoprotective effect of vitamins A and E on polyamine and oxygenated free radical metabolism in hairless mouse epidermis. Biochim 1998;70:1709-1713
35. Thompson SC, Jolley D, Marks R. Reduction of solar keratoses by regular sunscreen use. N Engl J Med 1993;329:1147-1151 (Pubitemid 23295456)
36. Alberts DS, Dorr RT, Einspahr JG, et al. Chemoprevention of human actinic keratoses by topical 2-(difluoromethyl)-DL-ornithine. Cancer Epidemiol Biomarkers Prev 2000;9:1281-1286